| AG-10300-277 |
5-Hydroxytryptamine (serotonin) Receptor 1A (HTR1A) |
| AG-10300-276 |
5-Hydroxytryptamine (serotonin) Receptor 1F (HTR1F) |
| AG-10200-231 |
5-Hydroxytryptamine (serotonin) Receptor 4 (HTR4) |
| AG-10200-237 |
5-Hydroxytryptamine (serotonin) Receptor 6 (HTR6) |
| AG-10200-240 |
5-Hydroxytryptamine (serotonin) Receptor 7B (HTR7B) |
| AG-10300-212 |
Adenosine A1 Receptor (ADORA1) |
| AG-10200-261 |
Adenosine A2a Receptor (ADORA2a) |
| AG-10200-252 |
Adenosine A2b Receptor (ADORA2B) |
| AG-10300-232 |
Adenosine A3 Receptor (ADORA3) |
| AG-10200-234 |
Adenylate Cyclase Activating Polypeptide 1 Receptor |
| AG-10200-271 |
Amylin 3 Receptor (Amy3R) |
| AG-10300-267 |
Angiotensin II Receptor-like 1 (AGTRL1) |
| AG-10200-246 |
Arginine Vasopressin Receptor 2 (AVPR2) |
| AG-10200-272 |
Beta 1 Andrenergic Receptor (ADRB1) |
| AG-10200-253 |
Beta 2 Andrenergic Receptor (ADRB2) |
| AG-10200-258 |
Calcitonin Receptor (CALCR) |
| AG-10200-251 |
Calcitonin Receptor-like (CALCRL) |
| AG-10300-205 |
Cannabinoid Receptor 1 (CB1) |
| AG-10300-225 |
Cannabinoid Receptor 2 (CB2) |
| AG-10300-213 |
Chemokine (C-Cmotif) Receptor 5 (CCR5) |
| AG-10300-265 |
Chemokine (C-X-Cmotif) Receptor 4 (CXCR4) |
| AG-10200-233 |
Corticotropin Releasing Hormone Receptor 2 (CRHR2) |
| AG-10200-249 |
Corticotropin Releasing Hormone Receptor1 (CRHR1) |
| AG-10200-218 |
Dopamine Receptor 1 (DRD1) |
| AG-10300-206 |
Dopamine Receptor 2 (DRD2) |
| AG-10200-222 |
Dopamine Receptor 5 (DRD5) |
| AG-10200-236 |
Follicle Stimulating Hormone Receptor (FSHR) |
| AG-10200-275 |
G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) |
| AG-10200-274 |
G Protein-Coupled Receptor 119 (GPR119) |
| AG-10200-221 |
Gastric Inhibitor Peptide Receptor (GIPR) |
| AG-10200-217 |
Glucagon Receptor (GCGR) |
| AG-10200-241 |
Glucagon-like Peptide 2 Receptor (GLP2R) |
| AG-10200-248 |
Glucagon-like-1 Receptor (GLPR1) |
| AG-10300-262 |
Glutamate Receptor, Metabotropic 2 (GRM2) |
| AG-10300-269 |
Glutamate Receptor, Metabotropic 4 (GRM4) |
| AG-10300-259 |
Glutamate Receptor, Metabotropic 7 (GRM7) |
| AG-10300-239 |
Glutamate Receptor, Metabotropic 8 (GRM8) |
| AG-10300-214 |
Melanin-Concentrating Hormone Receptor1 (MCHR1) |
| AG-10200-257 |
Melanocortin 1 Receptor (MC1R) |
| AG-10200-243 |
Melanocortin 3 Receptor (MC3R) |
| AG-10200-211 |
Melanocortin 4 Receptor (MC4R) |
| AG-10200-215 |
Melanocortin 5 Receptor (MC5R) |
| AG-10300-244 |
Neuropeptide Y Receptor Y1 (NPY1R) |
| AG-10300-245 |
Neuropeptide Y Receptor Y2 (NPY2R) |
| AG-10300-270 |
Neuropeptide Y Receptor Y4 (NPY4R) |
| AG-10300-280 |
Neuropeptide Y Receptor Y5 (NPY5R) |
| AG-10300-266 |
Opiate Receptor-like1 (OPRL1) |
| AG-10300-279 |
Opioid Receptor, Delta1 (OPRD1) |
| AG-10300-230 |
Opioid Receptor, Kappa 1 (OPRK1) |
| AG-10300-268 |
Opioid Receptor, Mu1 (OPRM1) |
| AG-10200-216 |
Parathyroid Hormone Receptor 1 (PTHR1) |
| AG-10200-228 |
Parathyroid Hormone Receptor 2 (PTHR2) |
| AG-10200-255 |
Prostaglandin D2 Receptor (PTGDR) |
| AG-10200-256 |
Prostaglandin E Receptor 2 (PTGER2) |
| AG-10200-219 |
Prostaglandin E Receptor 4 (EP4) |
| AG-10200-247 |
Prostaglandin I2 Receptor (PTGIR) |
| AG-10200-235 |
Secretin Receptor (SCTR) |
| AG-10300-207 |
Somatostatin Receptor 5 (SSTR5) |
| AG-10300-254 |
Sphingosine-1-Phosphate Receptor 1 (EDG1) |
| AG-10200-242 |
Thyroid Stimulating Hormone Receptor (TSHR) |
| AG-10200-220 |
Vasoactive Intestinal Peptide Receptor 1 (VIPR1) |
| AG-10200-209 |
Vasoactive Intestinal Peptide Receptor 2 (VIPR2) |
